HMGB1 and cardiac hypertrophy: Moreover, exogenous HMGB1 overexpression in myocardium not only promoted pressure overload‐induced cardiac hypertrophy but also aggravated LV systolic dysfunction in the long‐term, which may be reversed by HMGB1 box A, a competitive antagonist of HMGB1.